Statistics for Maravai LifeSciences Holdings (id:7336 MRVI)

Valuation metrics

Market cap

1.44B

Enterprise value

1.19B

Trailing P/E (ttm)

28.39

Forward P/E

289.00

PEG ratio

289.00

Price/Sales (ttm)

5.19

Price/Book (mrq)

1.85

Enterprise Value/Revenue

4.31

Enterprise Value/EBITDA

519.65

Overview

Shares outstanding

141.55M

Float

98.31M

Shares short

8.97M

% Held by insiders

0.01%

% Held by institutions

1.06%

Average volume (10 days)

3.03M

Average volume (90 days)

Price summary

52-Week low

4.28

52-Week high

11.56

52-Week change

2.10%

Beta

0.02

50-Day moving average

8.03

200-Day moving average

8.11

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

June 30th, 2024

Profitability

Profit margin

-81.13%

Operating margin

-23.09%

Operational effectiveness

Return on assets

-8.00%

Return on equity

-15.07%

Income statement

Revenue (ttm)

2.04

Revenue per share (ttm)

2.04

Quarterly revenue growth (yoy)

Gross profit (ttm)

140.20M

EBITDA

704.60M

Net income to common (ttm)

-224,660,000.00

Diluted EPS (ttm)

-1.67

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

579.75M

Total cash per share (mrq)

4.10

Total debt (mrq)

615.20M

Total Debt/Equity (mrq)

79.24

Current ratio (mrq)

999.77%

Book value per share (mrq)

3.09

Cash flow

Cash flow statement

102.98M

Levered free cash flow (LFCF)

-119,029,000.00